跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOSASPRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MOSASPRAY
Authorized
STANDARD
MOSASPRAY
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c2ad732e7397cc66
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
c2ad732e7397cc66
Drug Approval Canada Name
MOSASPRAY
Product Name
MOSASPRAY
Status
Cancelled Post Market
Status Date
2020-07-20
Original Market Date
2016-06-17
Din
02455870
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
OTC
Ahfs
52:08.08
Atc Original
R01AD09 MOMETASONE
Atc Name
r 01 ad 09
Aig Number
0121732002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE)
50 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c2ad732e7397cc66
Type
Standard
Back to Health Canada Approvals